PlugandPlay Health Invests in Modicus Prime and Facilitates Engagement with Pharmaceutical Partners
Modicus Prime has joined forces with PlugandPlay Health’s team to further accelerate pharmaceutical process development and save commercial drug production costs. Not only will Modicus have direct channels to PlugandPlays global pharmaceutical network, the company will receive a financial investment from the leading accelerator. Modicus has already been invited to present to Eli Lilly and Roche’s Vice Presidents of Digital Health in Indianapolis, IN, during the spring of 2023.
In addition to the financial backing and warm introductions, Modicus Prime will benefit from PlugandPlay’s Health accelerator program. “Developing a keen understanding of how to build a reproducible sales model is key,” said Taylor Chartier, CEO and founder of Modicus Prime. “Companies thrive from the mental models that PlugandPlay’s experts share with CEOs. I’m looking forward to honing our sales approach while expanding the company’s customer base.”
“Developing a keen understanding of how to build a reproducible sales model is key. Companies thrive from the mental models that PlugandPlay’s experts share with CEOs. I’m looking forward to honing our sales approach while expanding the company’s customer base.” - Taylor Chartier, CEO of Modicus Prime
About Modicus Prime
Modicus Prime’s computer vision software automates biologics image analysis and is designed to solve for the cost, legal, and waste liabilities from product quality failures across R&D and manufacturing. Modicus Prime is venture-backed and has strategic partnerships with organizations including Takeda Pharmaceuticals, Oak Ridge National Laboratory (DOE), eLabNext (Eppendorf), Dotmatics, PlugandPlay Health, and Techstars. Our proprietary GxP-compliant software, mpVision, enables scientists to independently train their own AI to achieve real-time classification of any imaging data - from biologic morphology analysis to commercial contamination detection – for comprehensive quality control across R&D and manufacturing. mpVision has been globally tested by scientists at Takeda Pharmaceuticals, and its features are mapped to the unmet needs of the pharmaceutical industry, including real-time product quality assurance, full agency compliance, faster go-to-market, and reduced operating costs.
To learn more about Modicus Prime, please visit https://modicusprime.com.